Literature DB >> 21570608

First-line chemotherapy of disseminated germ cell tumors.

Craig Nichols1, Christian Kollmannsberger.   

Abstract

The development of effective chemotherapy has been the defining event in the history of testicular cancer treatment. The discovery of cisplatin-based chemotherapy created a massive inflection that sharply defined the relatively grim precisplatin era from the astonishing postcisplatin era. The ripple effects of this discovery continue today with the rewriting of management of early-stage germ cell tumors to surveillance-based programs. This article reviews the discovery, development, and delivery of cisplatin-based chemotherapy; expected outcomes of chemotherapy treatment; remaining controversies in primary chemotherapy treatment of disseminated disease; and practical management tips for delivery of bleomycin, etoposide, and cisplatin and after chemotherapy treatment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570608     DOI: 10.1016/j.hoc.2011.03.011

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

Review 1.  Uptake carriers and oncology drug safety.

Authors:  Jason A Sprowl; Alex Sparreboom
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

2.  Single-cell microarray enables high-throughput evaluation of DNA double-strand breaks and DNA repair inhibitors.

Authors:  David M Weingeist; Jing Ge; David K Wood; James T Mutamba; Qiuying Huang; Elizabeth A Rowland; Michael B Yaffe; Scott Floyd; Bevin P Engelward
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

Review 3.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

Review 4.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

5.  A Systematic Review and Pooled Analysis of Studies of Oral Etoposide in Metastatic Breast Cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Eur J Breast Health       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.